Alphabetical list:
A B C D E F G H I J K L M N O P R S T U V W X Y Q Z 1 2 3 4 5 6 7 8 9
News: December 1, 2009
Ecstasy Users at Higher Risk of Sleep Apnea
December 1, 2009The widely used club drug ecstasy appears to increase the risk of sleep apnea, say U.S. researchers.
"People who use ecstasy need to know that this drug damages the brain and can cause immediate and dangerous problems such as sleep apnea," study author Dr. Una McCann, of the Johns Hopkins School of Medicine in Baltimore, said in a news release.
McCann and colleagues conducted sleep tests on 71 people who'd used ecstasy (MDMA) and 62 people who'd never used the illegal drug. Ecstasy users had a more than eight-fold increased risk of sleep apnea compared to non-users. Mild sleep apnea rates were similar in both groups (21 percent of ecstasy users and 27 percent of non-users), but only ecstasy users had moderate (13 percent) or severe (1 percent) sleep apnea.
The longer a person used ecstasy, the more sleep apnea episodes they experienced, said the researchers. They also found that ecstasy use was a greater risk factor for sleep apnea than obesity.
"Our findings may be explained by how ecstasy damages neurons related to serotonin, a chemical in the brain that is involved in sleep regulation and breathing, among other important functions," McCann said. "Sleep apnea in itself is dangerous, but it can also contribute to thinking problems in people who use ecstasy because chronic sleep disruption is known to have a negative effect on how a person functions during the daytime."
Archive issues: (50)
Archive list: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 [16] 17
October 17, 2011 | Sen. Grassley Seeks FDA Scrutiny of Paxil and Suicide RiskWASHINGTON, June 12, 2008 Senator Chuck Grassley has asked the Food and Drug Administration to carefully scrutinize information it received from drug maker GlaxoSmithKline about the anxiety disorder drug Paxil, based on the contents of a newly available report about the drug's risk for suicide among adults. Grassley also asked the FDA to review findings released ...
September 21, 2009 | Topical cream studied for erectile dysfunctionScientists from Albert Einstein College of Medicine of Yeshiva University are working on a cream to rub on and treat erectile dysfunction (ED). The cream could prove to be safer than oral medications used to deliver nitric oxide to the cells that improves blood flow to treat impotency. Using ...
May 21, 2012 | Onyx Rises on Analyst View of Blood Cancer DrugNEW YORK -- Onyx Pharmaceuticals Inc. shares rose Thursday after a Bernstein Research analyst started covering the stock with an "Outperform" rating, saying he thinks the company’s blood cancer drug candidate will reach $1 billion in annual sales by 2016. THE SPARK: Analyst Geoffrey Porges said he thinks that the drug, ...
Related articles:
Chronic prostatitis/chronic pelvic pain syndrome - treatment
A 2007 review article by Drs Potts and Payne in the Cleveland Clinic Journal of Medicine states: "Indeed, chronic abacterial prostatitis (also known as chronic pelvic pain syndrome) is both the most prevalent form and also the least understood and the most challenging to evaluate and treat. This form of prostatitis ...Section: Prostatitis
Stoicism and emotional repression
Society has different rules with regards to the way that men and women are supposed to express themselves. Men are generally regarded as the ones who are supposed to give comfort and strength. If they break down, cry, or seek comfort they may lose face. Women and other men do not give men an option to express feeling sad, tired, weak, depressed, inadequate, needy, or lonely without sacrificing their masculinity. Men are also four times more likely to commit suicide than women. Often, ...Section: Mens health risks
Chronic prostatitis/chronic pelvic pain syndrome - signs and symptoms
These patients have no history of genitourinary pain complaints, but leukocytosis is noted, usually during evaluation for other conditions.Section: Prostatitis